OXGR1
2-oxoglutarate receptor 1
Also known as: aKGR, GPR80, GPR99, OXGR1_HUMAN, P2RY15, P2Y15
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96P68
- Gene
- OXGR1
- Ensembl
- ENSG00000165621
- Chromosome
- 13
- Canonical length
- 337 aa
- Protein class
- G-protein coupled receptors, Predicted membrane proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
This gene encodes a G protein-coupled receptor (GPCR) that belongs to the oxoglutarate receptor family within the GPCR superfamily. The encoded protein is activated by the citric acid intermediate, oxoglutarate, as well as several cysteinyl leukotrienes, including leukotrienes E4, C4 and D4, which are implicated in many inflammatory disorders. In mice, a knock-out of this gene leads to middle ear inflammation, changes in the mucosal epithelium, and an increase in fluid behind the eardrum, and is associated with hearing loss. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
337 residues, UniProt reviewed canonical sequence.
>Q96P68|OXGR1
1 MNEPLDYLAN ASDFPDYAAA FGNCTDENIP LKMHYLPVIY GIIFLVGFPG NAVVISTYIF
61 KMRPWKSSTI IMLNLACTDL LYLTSLPFLI HYYASGENWI FGDFMCKFIR FSFHFNLYSS
121 ILFLTCFSIF RYCVIIHPMS CFSIHKTRCA VVACAVVWII SLVAVIPMTF LITSTNRTNR
181 SACLDLTSSD ELNTIKWYNL ILTATTFCLP LVIVTLCYTT IIHTLTHGLQ TDSCLKQKAR
241 RLTILLLLAF YVCFLPFHIL RVIRIESRLL SISCSIENQI HEAYIVSRPL AALNTFGNLL
301 LYVVVSDNFQ QAVCSTVRCK VSGNLEQAKK ISYSNNPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OXGR1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 7
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 2.8 nTPM
Expression across tissuesHPA
Tissue
- breast: 2.8 nTPM
- kidney: 2.6 nTPM
- salivary gland: 2.4 nTPM
- skin: 2 nTPM
- colon: 1.4 nTPM
- esophagus: 1.3 nTPM
Single-cell type
- extravillous trophoblasts: 71 nCPM
- renal collecting duct intercalated cells: 22 nCPM
- migrating cytotrophoblasts: 16 nCPM
- paneth cells: 7.7 nCPM
- lacrimal acinar cells: 7.2 nCPM
- lymphatic endothelial cells: 6.7 nCPM
Immune cell
- plasmacytoid DC: 1.3 nTPM
- myeloid DC: 0.7 nTPM
- classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
Brain region
- thalamus: 3.5 nTPM
- hypothalamus: 2.9 nTPM
- cerebral cortex: 1.9 nTPM
- midbrain: 1.9 nTPM
- medulla oblongata: 1.6 nTPM
- white matter: 1.6 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OXGR1.
Disease | AllUniProt
Conditions OXGR1 is implicated in, by any mechanism.
- Nephrolithiasis, calcium oxalate, 2, with nephrocalcinosis (CAON2) MIM:620374
Disease | GeneticClinVar
4 pathogenic / likely-pathogenic of 69 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Nephrolithiasis, calcium oxalate, 2, with or without nephrocalcinosis
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.59
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.09
- DepMap mean gene effect
- 0.02
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- G protein-coupled receptor signaling pathway
- innate immune response
- phospholipase C-activating G protein-coupled receptor signaling pathway
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OXGR1 as an antibody target. Whether an autoantibody or antibody against OXGR1 could matter depends on whether native OXGR1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OXGR1 is annotated at the cell surface, where native OXGR1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label OXGR1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...